Howard D. Thames
International Journal of Radiation Oncology, Biology, Physics · 2002–2016
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Howard D. Thames's perspective
Ordered by how strongly the researchers Howard D. Thames trusts endorse each paper. Same corpus, a different order for every researcher.
- Nonparametric Estimation from Incomplete Observations
- On the Criterion that a Given System of Deviations from the Probable in the Case of a Correlated System of Variables is Such that it Can be Reasonably Supposed to have Arisen from Random Sampling
- Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. (Journal of Clinical Oncology)
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. (Seminars in Radiation Oncology)
- Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. (New England Journal of Medicine)
- Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. (New England Journal of Medicine)
- Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. (New England Journal of Medicine)
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. (Radiotherapy and Oncology)
- Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. (New England Journal of Medicine)
Their papers
- HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). (2016)
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. (2006) — 2,746 citations
- Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue (2002) — 611 citations